Metabotropic glutamate receptor subtype 2 (mGluR2; GRM2); mGluR3 (GRM3) BriefCommunication Pages: 583 - 583
Prostaglandin E2 receptor EP4 subtype (prostanoid EP4 receptor; PTGER4) BriefCommunication Pages: 586 - 586
Vacuolar protein sorting 35 homolog (VPS35); VPS29; amyloid precursor protein (APP) BriefCommunication Pages: 587 - 587
Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 (HCN2) BriefCommunication Pages: 588 - 588
Serotonin (5-HT6) receptor; serotonin (5-HT7) receptor; dopamine D2 receptor BriefCommunication Pages: 589 - 589
Chemokine CX3C motif receptor 1 (CX3CR1); chemokine CX3C motif ligand 1 (CX3CL1; fractalkine) BriefCommunication Pages: 593 - 593
Assay to detect circulating methylated DNA (cMethDNA) to detect and monitor breast cancer BriefCommunication Pages: 594 - 594
Census-based, whole-exome sequencing of circulating tumor cells (CTCs) BriefCommunication Pages: 595 - 595
Nano-plasmonic exosome (nPLEX) sensor for high throughput, label-free, quantitative analysis of exosome proteins BriefCommunication Pages: 596 - 596
Total synthesis of polyene compounds with N-methyliminodiacetic acid (MIDA) boronate building blocks BriefCommunication Pages: 597 - 597
Cells with reduced N-glycan variability for therapeutic protein production BriefCommunication Pages: 598 - 598
Uracil enrichment in the seed region of single guide RNAs (sgRNAs) decreases off-target binding by the clustered, regularly interspaced short palindromic repeats (CRISPR)-Cas9 platform BriefCommunication Pages: 599 - 599
Monitoring oxygen levels in hypoxic tissues with a solid MRI contrast agent BriefCommunication Pages: 600 - 600
Creatine riboside and N-acetylneuraminic acid (NANA) levels in urine as biomarkers of non–small cell lung cancer (NSCLC) BriefCommunication Pages: 601 - 601